Wardwizard Healthcare Ltd will hold a Board meeting on 14 November 2025 to approve Q2 FY2025-26 unaudited standalone results, appoint a Chief Executive Officer, and reconstitute the Stakeholder Relationship Committee, with trading window restrictions in place through 16 November 2025.